Ironwood Pharmaceuticals | IRWD - Market Capitalization



Ironwood Pharmaceuticals reported $175.3M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
Agios Pharmaceuticals USD 1.93B 234M Jun/2025
Almirall EUR 2.29B 195.31M Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Ardelyx USD 1.51B 568M Sep/2025
Astellas Pharma JPY 2.56T 56.74B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Charles River Laboratories USD 7.37B 25M Jun/2025
Exact Sciences USD 10.02B 1.86B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
MacroGenics USD 111M 34M Sep/2025
Moderna USD 10.67B 290M Jun/2025
Pacira USD 1.11B 43M Jun/2025
PTC Therapeutics USD 3.87B 148M Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Takeda JPY 7.04T 19.15B Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025